{"id":1187,"date":"2025-11-09T10:35:36","date_gmt":"2025-11-09T15:35:36","guid":{"rendered":"https:\/\/emeddoc.org\/?p=1187"},"modified":"2025-11-09T10:35:37","modified_gmt":"2025-11-09T15:35:37","slug":"metoprolol-vs-diltiazem-for-atrial-fibrillation","status":"publish","type":"post","link":"https:\/\/emeddoc.org\/?p=1187","title":{"rendered":"Metoprolol vs Diltiazem for atrial fibrillation"},"content":{"rendered":"\n<p>And the question is: <em>Metoprolol vs. Diltiazem for atrial fibrillation?<\/em><\/p>\n\n\n\n<p>The more you explore this topic, the more fascinating and nuanced it becomes. When I wrote a chapter on this for <em><a href=\"https:\/\/www.amazon.com\/Management-Atrial-Fibrillation-Contemporary-Cardiology\/dp\/3319313843\" target=\"_blank\" rel=\"noreferrer noopener\">Short Stay Management of Atrial Fibrillation<\/a><\/em>, I initially thought we had thoroughly reviewed the evidence. However, during our later <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0735675724007538\" target=\"_blank\" rel=\"noreferrer noopener\">systematic review and meta-analysis,<\/a> we examined the data from a completely different perspective. <em>Annals of Emergency Medicine<\/em> even published a \u201cControversies\u201d section highlighting the ongoing debate around this issue. Ultimately, as much as you study the literature, the decision often comes down to your clinical style and comfort\u2014whether you prefer a calcium channel blocker or a beta blocker, both of which have their place depending on the patient and the clinical context.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0196064425003026?ref=pdf_download&amp;fr=RR-2&amp;rr=99be5e6d0e84d6b1\" target=\"_blank\" rel=\"noreferrer noopener\">Link to Calcium Channel Blockers<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/www.annemergmed.com\/article\/S0196-0644(25)01075-3\/abstract\" target=\"_blank\" rel=\"noreferrer noopener\">Link to BETA BLOCKERS<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>And the question is: Metoprolol vs. Diltiazem for atrial fibrillation? The more you explore this topic, the more fascinating and nuanced it becomes. When I wrote a chapter on this for Short Stay Management of Atrial Fibrillation, I initially thought we had thoroughly reviewed the evidence. However, during our later systematic review and meta-analysis, we [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21,13,14,15,16],"tags":[],"class_list":["post-1187","post","type-post","status-publish","format-standard","hentry","category-cardiology","category-pgy1","category-pgy2","category-pgy3","category-pgy4"],"_links":{"self":[{"href":"https:\/\/emeddoc.org\/index.php?rest_route=\/wp\/v2\/posts\/1187","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/emeddoc.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/emeddoc.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/emeddoc.org\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/emeddoc.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1187"}],"version-history":[{"count":1,"href":"https:\/\/emeddoc.org\/index.php?rest_route=\/wp\/v2\/posts\/1187\/revisions"}],"predecessor-version":[{"id":1189,"href":"https:\/\/emeddoc.org\/index.php?rest_route=\/wp\/v2\/posts\/1187\/revisions\/1189"}],"wp:attachment":[{"href":"https:\/\/emeddoc.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1187"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/emeddoc.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1187"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/emeddoc.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1187"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}